Trial Profile
Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2015
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 02 Apr 2015 New trial record